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ORIGINAL RESEARCH
Factors that Influence Perception of HIV Risk and Willingness 
to Use Pre-Exposure Prophylaxis in People Who Inject Drugs
Daria Egorova,1 Anny Fenton, PhD,2 Kinna Thakarar, DO, MPH3
1Tufts University School of Medicine, Boston MA, 2Dana Farber/Harvard Cancer Center, Boston MA, 3Maine Medical Center, 
Portland, ME
Introduction:  Sexual and injection behaviors increase the risk of HIV transmission in people who inject drugs 
(PWID). We aimed to determine the prevalence of sexual and drug behaviors that increase HIV risk in 
PWID hospitalized for infections related to injection drug use in Maine. We also examined factors that 
influenced their perception of HIV risk and willingness to take pre-exposure prophylaxis (PrEP).
Methods:  We surveyed 101 PWID with infections related to injection drug use who were hospitalized at 4 hospitals 
in Maine. T-tests assessed differences in means of bacterial infection risk scores and willingness to take 
PrEP based on different sociodemographic factors.
Results:  PWID engaging in unsafe sexual behavior had a higher mean score of bacterial infection risk than those 
engaging in safer sexual behavior (3.90 vs 3.07; P = .06). PWID with lower educational attainment 
had a lower mean score of willingness to take PrEP than those with a higher educational attainment 
(3.19 vs 3.85; P = .02). Willingness to take PrEP was positively associated with the level of educational 
attainment (odds ratio, 2.14; 95% CI, 1.01-4.93; P = .048).
Discussion:  Our findings associated willingness to take PrEP with educational attainment. To prevent HIV infection, 
harm reduction programs that discuss risk behaviors with PWID could be expanded, especially in rural 
areas where people have lower educational levels.
Conclusions:  We found that injection and sexual risk behaviors co-occurred in PWID, PWID had an overall perception 
of low HIV risk, and willingness to take PrEP was positively associated with the level of educational 
attainment.
Keywords:  HIV, substance use disorder, sexual behavior, pre-exposure prophylaxis, rural health services
People who inject drugs (PWID) are at risk for HIV infection and account for approximately 10% of new HIV diagnoses in the United 
States.¹ Risk factors for HIV transmission among 
PWID include sharing drug-injection equipment, 
such as needles, syringes, and cookers.¹ HIV 
transmission associated with unsafe injection 
practices can be minimized via access to syringe 
service programs (SSPs), in which PWID can 
exchange used needles and syringes for sterile 
ones. However, SSPs vary in distribution throughout 
the United States and are largely inaccessible to 
PWID from more rural areas like Maine.2,3 Several 
studies have noted that sexual risk behaviors (eg, 
having sex in exchange for money, inconsistent 
condom use, having multiple sexual partners) tend 
to co-occur with unsafe injection behaviors in PWID 
and may contribute to the spread of HIV.4
Prior studies also note that a constellation of 
psychosocial vulnerabilities (eg, stigma associated 
with drug use and HIV) may underlie why people 
either abstain from sex or pursue unsafe sex (with 
a relative unlikelihood to engage in safer sex).5 To 
reduce HIV incidence in PWID who are at high risk 
of HIV infection, the Centers for Disease Control 
and Prevention recommend a daily dose of oral pre-
exposure prophylaxis (PrEP).⁶ However, people can 
face several challenges in accessing PrEP. Some 
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reasons for low uptake and adherence include 
stigma associated with PrEP use, a perception of 
low HIV risk, and a daily dosing regimen of the drug.7 
Providers also may not view injection drug use as 
a significant risk factor for HIV and consequently 
abstain from discussing PrEP and prescribing the 
drug to PWID.8,9
These challenges underscore the importance of 
optimizing PrEP uptake in PWID from largely rural 
states such as Maine, where there were only 7 
operational SSPs in 2019-2020 when this study 
was conducted. In this study, we aimed to better 
understand risk-taking behaviors and attitudes 
toward PrEP use among PWID. We set out to 
determine the prevalence of sexual and drug 
behaviors that increase HIV risk for PWID and 
examine factors that influence the perception of 
HIV risk and willingness to take PrEP among PWID 
in a rural state.
METHODS
Study design
This study is a cross-sectional analysis of PWID 
with infections associated with injection drug use 
who were hospitalized at 4 hospitals in Maine 
between January, 2019 and March, 2020.3 Data 
were collected through the electronic health record 
and an audio computer-assisted survey as part of 
a larger initial 18-month cross-sectional study.3 
We focused our data analysis on survey questions 
specific to sexual behaviors, injection practices, HIV 
awareness, and attitudes toward drug programs. 
The MaineHealth Institutional Review Board 
approved this study.
PRIMARY OUTCOME
The primary outcome was willingness to use PrEP, 
which was measured by answers to the question, 
“How willing would you be to take a pill a day (pre-
exposure prophylaxis, ie, PrEP) if you thought it 
would decrease your chances of getting HIV?” 
Responses were on a 5-point Likert scale ranging 
from “very unwilling” to “very willing” (Table 1).
VARIABLES
Demographics. “Rural” was defined as “isolated 
rural,” “small rural,” and “large rural.” An area’s 
rurality was determined based on the rural-
urban commuting area (RUCA) code associated 
with a participant’s ZIP code.¹⁰ Insurance was 
collected through the electronic health record and 
categorized. A collapsed category of “Insured” 
participants was created. This category consisted 
of anyone who stated that they are insured under 
“Medicaid,” “Medicare,” “Dual Medicare/Medicaid,” 
or through “Commercial” insurance. “Uninsured” 
participants were those who reported they had “No 
insurance.”
Secondary outcome. The Bacterial Infections 
Risk Scale for Injectors (BIRSI)-7, a 7-item index, 
was used to measure unsafe injection behavior, 
such that a higher score indicated poorer hygiene 
and practice.¹¹ The BIRSI-7 score was based on a 
combination of different injection practices, such 
as the frequency of re-using cookers and filters, 
handwashing before injecting, and cleaning skin 
before injecting.
Independent variables. Unsafe sexual behavior 
was assessed based on yes/no responses to 
behavioral questions about using condoms during 
the last sexual encounter; not having sex in 
exchange for money, drugs, or a place to stay; and 
not having sex with other PWID. Respondents were 
classified as engaging in “unsafe sexual behavior” 
if they answered yes to engaging in at least one 
unsafe sexual behavior. Perception of HIV risk was 
categorized as “low” if a participant answered that 
they are “very unlikely” or “somewhat unlikely” to 
become infected with HIV from either injecting drugs 
or having sex in the next 6 months. Perception of 
HIV risk was categorized as “high” if participants 
answered that they are “very likely,” “somewhat 
likely,” or “neither likely nor unlikely” to become 
infected with HIV. Other variables in Table 1 were 
collected via self-report.
STATISTICAL ANALYSIS
T-tests were conducted to compare differences 
between means of PrEP willingness and 
sociodemographic characteristics, such as sex, 
sexual orientation, experiencing homelessness, 
health insurance status, RUCA codes, educational 
attainment, and perception of HIV risk from injection 
behavior and sexual behavior. Separate t-tests were 
also performed to establish differences in means of 
BIRSI-7 scores between PWID with safer sexual 
behavior versus those with unsafe sexual behavior.
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Table 1. Select Characteristics of Study Participants
Sociodemographic Data value*
Sex, N (%) 
  Male 44 (44)
  Female 57 (56)
Age, y, median (IQR) 35 (31-40)
Race, N (%)
  White 95 (94)
  Black 1 (1)
  Hispanic 0 (0)
  Unknown 2 (2)
  Other 3 (3)
Sexual orientation, N (%)
  Heterosexual 83 (82)
  Bisexual 16 (16)
  Gay or lesbian 2 (2)
Experiencing homelessness, N (%) 46 (46)
RUCA codes, N (%)
  Urban 66 (65)
  Rural 35 (35)
Educational attainment, N (%)
  High school, GED, or less 62 (61)
  2- to 4-year college degree or some college (no degree) 39 (39)
Health insurance status†, N (%)
  Uninsured 25 (25)
  Insured 74 (75)
Injection risk behavior
  BIRSI-7 score, average (SD) 3.77 (1.61)
Sexual risk behavior
  Number of sexual contacts 30 days before hospitalization, median 1
  No condom during last sexual encounter, N (%) 78 (78)
  Sex in exchange for money/drugs/place to stay, N (%) 12 (12)
  Sex with people who inject drugs, N (%) 45 (46)
HIV testing
  Ever tested for HIV, N (%) 95 (95)
  How many times tested, average 4
Willingness to take PrEP, N (%)
  Very willing 31 (31)
  Somewhat willing 23 (23)
  Neutral 23 (23)
  Somewhat unwilling 8 (8)
  Very unwilling 16 (16)
Discussed PrEP with health care provider 8 (8%)
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Table 2. PrEP Willingness by Patient Characteristics
Patient characteristics
Willingness to 
take PrEP* P value
Sex
.43  Female (N= 57) 3.54
  Male (N= 44) 3.32
Sexual Orientation
.47  Heterosexual (N= 83) 3.40
  Bisexual, gay, or lesbian (N= 18) 3.67
Experiencing homelessness
.83  Yes (N= 46) 3.48
  No (N= 55) 3.42
Health insurance status
.83  Insured (N= 74) 3.43
  Uninsured (N= 25) 3.36
RUCA codes
.03  Rural (N= 35) 3.03
  Urban (N= 66) 3.67
Education
.02  High school, GED, or less (N= 62) 3.19
  Some college or 2- to 4-year degree (N= 39) 3.85
Perception of HIV risk from injection behavior
.23  Low (N= 84) 3.41
  High (N= 8) 4.00
Perception of HIV risk from sexual behavior
.68  Low (N= 88) 3.45
  High (N= 4) 3.75
Abbreviations: GED, General Educational Development; PrEP, pre-exposure prophylaxis; RUCA, 
rural-urban commuting area.
*Willingness to take PrEP was based on responses to a 5-point Likert scale ranging from “very 
unwilling” to “very willing.” A higher number corresponds to a higher willingness to take PrEP once 
daily to decrease the chances of HIV infection.
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To test whether certain sociodemographic 
factors contributed more than others to observed 
differences, an ordered logit was performed. The 
primary outcome was willingness to use PrEP, 
controlling for rurality and educational attainment. 
These 2 sociodemographic factors were chosen 
for the ordered logit based on previous studies 
examining sexual risk among PWID.⁴,⁸ For other 
covariates that were considered in the original 
model, refer to Table 1. All analyses were performed 
using Stata Version 16.0.12
RESULTS
This study included 101 participants. Among the 
participants, 31% stated that they were “very willing” 
and 23% stated that they were “somewhat willing” to 
take PrEP. Also, 8% of participants stated that they 
were “somewhat unwilling” and 16% of participants 
stated that they were “very unwilling” to take PrEP 
(Table 1). PWID with lower educational attainment 
status (high school, GED [General Educational 
Development], or less) had a lower mean score 
of willingness to take PrEP than those with higher 
educational attainment (3.19 vs 3.85; P = .02). 
PWID from rural areas had a lower mean score of 
PrEP willingness than those from urban areas (3.03 
vs 3.67; P = .03). Among the participants, 84/92 
(91%) had a perception of low HIV risk from injecting 
drugs, and 88/92 (96%) had a perception of low 
HIV risk from sexual behavior (Table 2). Individuals 
engaging in unsafe sexual behavior (N= 83) had a 
marginally higher mean BIRSI-7 score than those 
engaging in safer sexual behavior (N= 15) (3.07 vs 
3.90; P = .06) (Figure 1). In our regression model, 
willingness to take PrEP was positively associated 
with the level of educational attainment (adjusted 
odds ratio, 2.14; 95% CI, 1.01-4.93, P = .048).
DISCUSSION
Findings from this study with hospitalized PWID 
suggest that PWID with a lower level of educational 
attainment are less willing to take PrEP to decrease 
their chances of HIV infection. Hospitalized PWID 
from rural areas are similarly less willing to take PrEP. 
Our regression model indicated that willingness to 
take PrEP was positively associated with level of 
educational attainment. The perception of HIV risk 
from injection drug use and sexual behavior was 
low among hospitalized PWID, although most 
PWID reported engaging in unsafe sexual behavior 
and unsafe injection drug use. PWID engaging in 
safer sexual behavior had a lower BIRSI than those 
engaging in unsafe sexual behavior, although this 
finding was not significant.
Figure 1. Co-occurrence of Injection and Sexual-Related Risk Behavior in PWID
(N=101). Abbreviations: BIRSI-7, Bacterial Infections Risk Scale for Injectors
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IMPLICATIONS
The positive association between educational 
attainment and willingness to take PrEP 
highlights the importance of targeting future HIV 
prevention efforts toward PWID in rural areas, 
where individuals have disproportionately lower 
educational levels. The perception of low HIV risk 
among PWID who participate in unsafe sexual and 
injection-related behaviors and across different 
sociodemographic characteristics supports the 
importance of expanding SSPs throughout Maine. 
These programs discuss risk behavior with PWID 
and could help this population understand why they 
are at high risk for HIV.3 Given the co-occurrence of 
injection and sexual-related risk behaviors in PWID, 
our findings support that comprehensive efforts 
to prevent HIV in PWID should include evaluating 
sexual risk for HIV transmission.
Limitations
Our study had several limitations. Our sample size 
was small (N= 101) and underpowered to address our 
study question. Not all participants answered every 
survey question, decreasing the sample size for our 
analyses. Notably, only 92 participants responded 
to the questions regarding HIV risk perception from 
drug use/sexual behavior. Also, only 98 participants 
responded to questions regarding condom use 
during their last sexual encounter; having sex in 
exchange for money, drugs, or a place to stay; 
and having sex with people who inject drugs. We 
attribute the lack of statistical significance in mean 
BIRSI-7 scores between PWID engaging in safer 
sexual behavior versus those engaging in unsafe 
sexual behavior to the small sample size.
Although the PWID in this our may be good 
representatives of groups at risk for HIV in 
Maine, findings from our population may not 
be generalizable to other geographic regions 
within the United States. Similarly, because our 
participants were all hospitalized with an injection-
related infection, our sample may not represent 
PWID who are at lower risk of developing infectious 
complications from drug use. Most participants in 
this study self-identified as white and heterosexual, 
further limiting generalizability to more diverse 
populations. Further research would benefit from 
sampling a larger, more diverse population of 
PWID to assess the prevalence of HIV-related risk 
behaviors and interest in PrEP.
CONCLUSIONS
Our findings suggest overlap in the co-occurrence 
of injection-related and sexual-related risk behavior 
in PWID. We also noted an overall perception of 
low HIV risk in PWID, despite participation in unsafe 
behavior, and we provided information about factors 
that may influence willingness to use PrEP.
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